Question 1

What are the expected benefits of switching to bimatoprost or travoprost from latanoprost?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% clinical trial (NCT00440011). Contact the study team or your healthcare provider for specific answers.

Question 2

How might these treatments affect my current eye health and vision?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% clinical trial (NCT00440011). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with these new eye drops?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% clinical trial (NCT00440011). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my eye pressure be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% clinical trial (NCT00440011). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific instructions I need to follow while using these eye drops?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% clinical trial (NCT00440011). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience any adverse effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% clinical trial (NCT00440011). Contact the study team or your healthcare provider for specific answers.

What this study is about